HOTH stock has scam price action. But company is on a good track operation/r&d wise. Either we see 3+ going up and up as a 25x story; or we might face scamming price action because the traders behind it are treating it as such. Phase 3 after that is the launch as for the dermatology drug developments.
HOTH - 1.10 Up .30 In after hours. News out at the bell.
Hoth Therapeutics shares are trading higher after the company was granted U.S. Patent No. 12,144,815 titled "Use of Aprepitant for Treating Alzheimer's Disease."